Live Webinar: Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis

Monday 22nd June 2020

Eric Vivier provides a longitudinal analysis of immune responses, including immune cell phenotyping and assessments of the soluble factors present in the blood and broncho-alveolar lavage fluid (BALF) of patients at various stages of COVID-19 severity: paucisymptomatic, pneumonia and acute respiratory distress syndrome (ARDS).

He reports an increase in soluble C5a levels proportional to COVID-19 severity and high levels of C5aR1 expression in blood and pulmonary myeloid cells, supporting a role for the C5a-C5aR1 axis in the pathophysiology of ARDS.

Anti-C5aR1 therapeutic monoclonal antibodies (mAbs) prevented C5a-mediated human myeloid cell recruitment and activation, and inhibited acute lung injury (ALI) in human C5aR1 knockin mice.

These results support C5a-C5aR1 axis blockade as a means of limiting myeloid cell infiltration in damaged organs and preventing the excessive lung inflammation and endothelialitis associated with ARDS in COVID-19 patients.

Join the webinar: IUIS-Frontiers Webinar Series on COVID-19


Event Details


Upcoming Events

7th European Veterinary Immunology Workshop

Sunday 29th August 2021

6th European Congress of Immunology – ECI 2021

Wednesday 1st September 2021

17th International Workshop on Langerhans Cells and Related Myeloid Cells of the Skin

Sunday 3rd October 2021 at To be determined

Cytokines 2021: 9th Annual Meeting of the International Cytokine & Interferon Society – CELTIC CYTOKINES SENSING AND INTERPRETING CYTOKINE & INTERFERON CUES

Sunday 17th October 2021

FIMSA 2021

Sunday 31st October 2021 at BEXCO

ALACI 2021

Monday 1st November 2021 at Varadero, Cuba

International Primary Immunodeficiencies Congress 2021 (IPIC)

Wednesday 3rd November 2021

IPIC 5th Edition

Wednesday 27th April 2022 at Centro de Congressos do Algarve

Cytokines 2022: 10th Annual Meeting of the International Cytokine & Interferon Society

Tuesday 20th September 2022